1. Home
  2. NOTV vs ZDGE Comparison

NOTV vs ZDGE Comparison

Compare NOTV & ZDGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • ZDGE
  • Stock Information
  • Founded
  • NOTV 1974
  • ZDGE 2008
  • Country
  • NOTV United States
  • ZDGE United States
  • Employees
  • NOTV N/A
  • ZDGE N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • ZDGE Computer Software: Prepackaged Software
  • Sector
  • NOTV Health Care
  • ZDGE Technology
  • Exchange
  • NOTV Nasdaq
  • ZDGE Nasdaq
  • Market Cap
  • NOTV 126.3M
  • ZDGE 50.5M
  • IPO Year
  • NOTV 1997
  • ZDGE N/A
  • Fundamental
  • Price
  • NOTV $4.22
  • ZDGE $2.55
  • Analyst Decision
  • NOTV Strong Buy
  • ZDGE
  • Analyst Count
  • NOTV 3
  • ZDGE 0
  • Target Price
  • NOTV $5.92
  • ZDGE N/A
  • AVG Volume (30 Days)
  • NOTV 1.5M
  • ZDGE 235.2K
  • Earning Date
  • NOTV 02-05-2025
  • ZDGE 12-16-2024
  • Dividend Yield
  • NOTV N/A
  • ZDGE N/A
  • EPS Growth
  • NOTV N/A
  • ZDGE N/A
  • EPS
  • NOTV N/A
  • ZDGE N/A
  • Revenue
  • NOTV $490,739,000.00
  • ZDGE $30,204,000.00
  • Revenue This Year
  • NOTV $7.14
  • ZDGE $0.34
  • Revenue Next Year
  • NOTV $5.73
  • ZDGE $6.35
  • P/E Ratio
  • NOTV N/A
  • ZDGE N/A
  • Revenue Growth
  • NOTV N/A
  • ZDGE 10.15
  • 52 Week Low
  • NOTV $1.23
  • ZDGE $1.93
  • 52 Week High
  • NOTV $11.42
  • ZDGE $5.18
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 48.58
  • ZDGE 47.33
  • Support Level
  • NOTV $4.17
  • ZDGE $2.42
  • Resistance Level
  • NOTV $5.67
  • ZDGE $2.64
  • Average True Range (ATR)
  • NOTV 0.55
  • ZDGE 0.31
  • MACD
  • NOTV -0.11
  • ZDGE -0.01
  • Stochastic Oscillator
  • NOTV 22.87
  • ZDGE 23.68

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About ZDGE Zedge Inc. Class B

Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.

Share on Social Networks: